Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters

Applied and Environmental Microbiology

Volumn 79, Issue 2, 2013, Pages 516-524

  Martínez, Inés ^a   Perdicaro, Diahann J ^a   Brown, Andrew W ^a   Hammons, Susan ^a   Carden, Trevor J ^a   Carr, Timothy P ^a   Eskridge, Kent M ^a   Walter, Jens ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL ACTION; ANTIBACTERIAL EFFECTS; BACTERIAL INHIBITION; BACTERIAL TAXA; CHOLESTEROL METABOLISM; FECAL MICROBIOTA; FUNCTIONAL CONNECTION; IN-VITRO; LIPID METABOLISMS; MAMMALIAN HOSTS; METABOLIC PATHWAYS; METABOLIC PHENOTYPE; MICROBIAL COMMUNITIES; MICROBIOTAS; NON-LINEAR MODEL; PLANT STEROL ESTERS; PLANT STEROLS;

ALCOHOLS; BODY FLUIDS; MAMMALS; METABOLISM; PHYSIOLOGY;

CHOLESTEROL;

CHOLESTEROL;

ABUNDANCE; DIET; HOST-PARASITE INTERACTION; INHIBITION; LIPID; METABOLISM; MICROORGANISM; PHENOTYPE; RODENT; TAXONOMY;

ANIMAL; ARTICLE; BACTERIUM; BIODIVERSITY; CLASSIFICATION; DIET; FECES; GASTROINTESTINAL TRACT; HAMSTER; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY;

ANIMALS; BACTERIA; BIODIVERSITY; CHOLESTEROL; CRICETINAE; DIET; FECES; GASTROINTESTINAL TRACT;

BACTERIA (MICROORGANISMS); CORIOBACTERIACEAE; CRICETINAE; ERYSIPELOTRICHACEAE; MAMMALIA;

EID: 84871886012     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03046-12     Document Type: Article

References (50)

1. Allen CA, Torres AG. 2008. Host-microbe communication within the GI tract. Adv. Exp. Med. Biol. 635:93-101.
2. Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J, Paris A, Want EJ, de Waziers I, Cloarec O, Richards SE, Wang Y, Dumas ME, Ross A, Rezzi S, Kochhar S, Van Bladeren P, Lindon JC, Holmes E, Nicholson JK. 2011. Colonization-induced host-gut microbial metabolic interaction. mBio 2:e00271-10. doi:10.1128/mBio.00271-10.
3. Tremaroli V, Backhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489:242-249.
4. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-1920.
5. Cani PD, Delzenne NM. 2009. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr. Opin. Pharmacol. 9:737-743.
6. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sorensen SJ, Hansen LH, Jakobsen M. 2010. Gut microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PLoS One 5:e9085. doi:10.1371/journal.pone.0009085.
7. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102:11070-11075.
8. Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. 2011. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140:976-986.
9. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, Krajmalnik-Brown R. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U. S. A. 106:2365-2370.
10. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101:15718-15723.
11. Danielsson H, Gustafsson B. 1959. On serum-cholesterol levels and neutral fecal sterols in germ-free rats; bile acids and steroids 59. Arch. Biochem. Biophys. 83:482-485.
12. Wostmann BS. 1973. Intestinal bile acids and cholesterol absorption in the germfree rat. J. Nutr. 103:982-990.
13. de Vos WM, de Vos EA. 2012. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 70(Suppl. 1):S45-S56.
14. Yokota A, Fukiya S, Ooka T, Ogura Y, Hayashi T, Ishizuka S. 2012. Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes 3:455-459.
15. Martínez I, Wallace G, Zhang C, Legge R, Benson AK, Carr TP, Moriyama EN, Walter J. 2009. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl. Environ. Microbiol. 75:4175-4184.
16. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, Zhao G, Chen Y, Zhao L. 2010. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4:232-241.
17. Mitchell PL, McLeod RS. 2008. Conjugated linoleic acid and atherosclerosis: studies in animal models. Biochem. Cell Biol. 86:293-301.
18. Angulo AF, Spaans J, Zemmouchi L, van der Waaij D. 1978. Selective decontamination of the digestive tract of Syrian hamsters. Lab. Anim. 12:157-158.
19. Rasmussen HE, Guderian DM, Jr, Wray CA, Dussault PH, Schlegel VL, Carr TP. 2006. Reduction in cholesterol absorption is enhanced by stearate-enriched plant sterol esters in hamsters. J. Nutr. 136:2722-2727.
20. Brown AW, Hang J, Dussault PH, Carr TP. 2010. Phytosterol ester constituents affect micellar cholesterol solubility in model bile. Lipids 45: 855-862.
21. Brown AW, Hang J, Dussault PH, Carr TP. 2010. Plant sterol and stanol substrate specificity of pancreatic cholesterol esterase. J. Nutr. Biochem. 21:736-740.
22. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. 1991. Mechanisms of action of plant sterols on inhibition of cholesterol absorption. Comparison of sitosterol and sitostanol. Eur. J. Clin. Pharmacol. 40(Suppl. 1):S59-S63.
23. Normen L, Dutta P, Lia A, Andersson H. 2000. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am. J. Clin. Nutr. 71:908-913.
24. Ntanios FY, Jones PJ. 1999. Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis 143:341-351.
25. Roberts PJ, Riley GP, Morgan K, Miller R, Hunter JO, Middleton SJ.2001. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J. Clin. Pathol. 54:293-297.
26. Trautwein EA, Duchateau GSMJE, Lin Y, Mel'nikov SM, Molhuzien HOF, Ntanios FY. 2003. Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur. J. Lipid Sci. Technol. 105:171-185.
27. Macdougall J. 2006. Analysis of dose-response studies-Emax model. In Ting N (ed), Dose finding in drug development. Springer, New York, NY.
28. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. 2005. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J. Antimicrob. Chemother. 55:601-607.
29. Schneider CL, Cowles RL, Stuefer-Powell CL, Carr TP. 2000. Dietary stearic acid reduces cholesterol absorption and increases endogenous cholesterol excretion in hamsters fed cereal-based diets. J. Nutr. 130:1232-1238.
30. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7:335-336.
31. Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73:5261-5267.
32. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. 2010. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 5:e15046. doi:10.1371/journal.pone.0015046.
33. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
34. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
35. Mukhopadhyay S, Maitra U. 2004. Chemistry and biology of bile acids. Curr. Sci. 87:1666-1682.
36. Do TQ, Moshkani S, Castillo P, Anunta S, Pogosyan A, Cheung A, Marbois B, Faull KF, Ernst W, Chiang SM, Fujii G, Clarke CF, Foster K, Porter E. 2008. Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J. Immunol. 181:4177-4187.
37. Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O'Callaghan RJ. 2007. Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea. Investig. Ophthalmol. Vis. Sci. 48: 2661-2666.
38. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. 2012. Dietary-fatinduced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 487:104-108.
39. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11:76-83.
40. Floch MH, Gershengoren W, Elliott S, Spiro HM. 1971. Bile acid inhibition of the intestinal microflora-a function for simple bile acids? Gastroenterology 61:228-233.
41. Stacey M, Webb M. 1947. Studies on the antibacterial properties of the bile acids and some compounds derived from cholanic acid. Proc. R. Soc. Med. 134:523-537.
42. Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. 2011. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141:1773-1781.
43. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 104:979-984.
44. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481.
45. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228-231.
46. Chen JJ, Wang R, Li XF, Wang RL. 2011. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp. Biol. Med. 236:823-831.
47. Kiessling G, Schneider J, Jahreis G. 2002. Long-term consumption of fermented dairy products over 6 months increasesHDLcholesterol. Eur. J. Clin. Nutr. 56:843-849.
48. Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K. 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci. Biotechnol. Biochem. 74:1656-1661.
49. Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. 2010. The effects of probiotic and conventional yoghurt on lipid profile in women. Br. J. Nutr. 103:1778-1783.
50. Yin YN, Yu QF, Fu N, Liu XW, Lu FG. 2010. Effects of four bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16: 3394-3401.